Tilray Brands (TSX:TLRY) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 12, 2026)


TSX:TLRY Tilray Brands Inc TSX:TLRY
58 GF Score
Price C$6.23
GF Value C$17.39
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Tilray Brands 5-Year Yield-on-Cost %?

Tilray Brands TSX:TLRY +0.32% 58 5-Year Yield-on-Cost % is 0.00 as of Jul. 12, 2026. GuruFocus rates TSX:TLRY with a GF Score™ of 58/100 and a GF Value™ of C$17.39 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 516 Drug Manufacturers companies, Tilray Brands ranks worse than 193798.26% on this metric.

Tilray Brands's yield on cost for the quarter that ended in Feb. 2026 was 0.00.


The historical rank and industry rank for Tilray Brands's 5-Year Yield-on-Cost % or its related term are showing as below:



TSX:TLRY's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.205
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Tilray Brands  (TSX:TLRY) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Tilray Brands 5-Year Yield-on-Cost % Related Terms


TSX:TLRY vs AQST, EOLS, NIKA: 5-Year Yield-on-Cost % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tilray Brands 5-Year Yield-on-Cost % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Tilray Brands's 5-Year Yield-on-Cost % falls into.


TSX:TLRY
58GF Score
Tilray Brands Inc TSX:TLRY
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tilray Brands 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Tilray Brands is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Tilray Brands (TSX:TLRY) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 12, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Tilray Brands and its competitors. According to the industry distribution chart, Tilray Brands ranks #999999 out of 516 companies in the Drug Manufacturers industry.
Is Tilray Brands' 5-Year Yield-on-Cost % too high?
Tilray Brands' current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Tilray Brands ranks #999999 out of 516 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Tilray Brands has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tilray Brands' 5-Year Yield-on-Cost % compare to AQST and EOLS?
According to the Drug Manufacturers industry distribution chart, Tilray Brands ranks #999999 out of 516 companies for 5-Year Yield-on-Cost %. This places Tilray Brands in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.21, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Tilray Brands and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tilray Brands's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tilray Brands stock overvalued right now?
Based on GuruFocus' analysis, Tilray Brands (TSX:TLRY) is currently considered Possible Value Trap. The stock's GF Value™ is C$17.39, compared to a current price of C$6.23 — trading 64.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Tilray Brands' overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Tilray Brands (TSX:TLRY), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tilray Brands (TSX:TLRY) Overvalued in 2026?

Based on GuruFocus' analysis, Tilray Brands stock appears to be undervalued. The current stock price of C$6.23 is trading 64.2% below its estimated GF Value™ of C$17.39. GuruFocus considers Tilray Brands to be Possible Value Trap.

Key valuation signals for TSX:TLRY:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: C$17.39 vs. price of C$6.23 (64.2% below fair value)
  • GF Score™: 58/100 with 5 warning signs

No single metric tells the full story. See the TSX:TLRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tilray Brands Business Description

Address 265 Talbot Street West, Leamington, ON, CAN, N8H 5L4
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
58GF Score

Get the complete analysis for TSX:TLRY

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$6.23
Price
C$17.39
GF Value